Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Oslo University Hospital
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Treating the gut flora to improve heart failure
The main objective of the study is to investigate the gut microbiota as a potential therapeutic target in HF: • By characterizing the composition of gut microbiota in HF patients compared to health...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
PHASE I/IIa STUDY OF VACCINE THERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Immunological response to UV1 vaccine and assessment of safety and tolerability of UV1.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Opioid induced hypersensitivity: possible to avoid by different withdrawal regimens?
Comparing gradual reduction from remifentanil infusion to acute withdrawal with regards to opioid induced hyperalgesia.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
A phase II study of pembrolizumab in patients with malignant peripheral nerve sheath tumor (MPNST), not eligible for curative surgery
Main Objective: To evaluate the percentage of patients with curatively unresectable MPNST who have achieved clinical response; complete response (CR), partial response (PR), or stable disease (SD) at ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Therapeutic effects of a cardiac hormone, named BNP, in patients with poorly controlled high levels of blood pressure
To demonstrate safety and to determine most effective dose of subcutaneous nesiritide in patients with UHT.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Clinical study with cancer vaccine combined with Anti-PD1 (Pembrolizumab) in malignant lymphoma
The main objectives of the trial is to induce systemic immune responses against the lymphoma and correlated clinical responses, and additionally study feasibility and safety
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
A national phase IV study with Ipilimumab for patients with advanced malignant melanoma
•To estimate the incidence and severity of adverse reactions in adult patients treated with ipilimumab in the post-approval setting. •To describe the management of adverse reactions (eg, diarrhea, co...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
Expectations among musculoskeletal patients
Background and study aims Patients’ expectations may be linked to their characteristics and the outcome of their treatment. However, few studies have investigated if or how physical medicine and rehab...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital (Norway)
MAJ Il y a 4 ans
The COPE LBP trial: Cognitive Patient Education for Low Back Pain
Not provided at time of registration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Oslo University Hospital
MAJ Il y a 4 ans
ADJUVANT CHEMOTHERAPY IN ELDERLY CRC– ACE Study
The main objective is to investigate the tolerance of adjuvant chemotherapy, measured by functional decline, after surgery for colon cancer stage III in elderly patients.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
1
2
3
4
Suivant